DUBLIN--(BUSINESS WIRE)--The "Urinary Self-Catheters Market by Product Type, Type, and Application: Global Opportunity Analysis and Industry Forecast, 2019-2026" report has been added to ResearchAndMarkets.com's offering.
According to the report, the global urinary self-catheters market size was valued at $1,722 million in 2018, and is expected to reach $2,387 million by 2026, growing at a CAGR of 4.1% from 2019 to 2026.
The urinary self-catheters market is expected to experience significant growth during the forecast period, owing to rise in demand for hydrophilic intermittent catheter across geographies. Furthermore, surge in number of prostate surgeries; increase in prevalence of benign prostate hyperplasia, urinary incontinence, and spinal cord injuries; upsurge in geriatric population, and implementation of favorable reimbursement policies for usage of intermittent catheters boost the growth of the urinary self-catheters market during the forecast period. However, availability of alternatives for usage of self-catheters hampers the market growth.
Based on product, the market is categorized as intermittent catheters and external catheters. At present, the intermittent catheters segment dominates the global market, and is anticipated to remain dominant during the forecast period. Some key factors that drive the growth of this segment include rise in demand for intermittent catheters, favorable reimbursement policies for usage of these catheters, wide availability of intermittent catheters at affordable price, and increase in target population.
Based on type, the global urinary self-catheters market is dominated by male type catheter, due to rise in prevalence of benign prostate hyperplasia (BPH), increase in number of prostate surgery, and surge in number of patients with urinary retention.
Based on application, spinal cord injuries segment was the major revenue contributor in 2018, owing to rise in incidence of spinal cord injuries and increase in adoption of self-intermittent catheters. However, the benign prostate hyperplasia segment is anticipated to exhibit the fastest growth during the forecast period, owing to increase in prevalence of benign prostate hyperplasia, rise in adoption of intermittent catheters, and surge in male geriatric population.
North America accounted for approximately one-half of the global urinary self-catheters market share in 2018, and is expected to remain dominant throughout the forecast period. This was attributed to rise in higher adoption of urinary self-catheters, presence of well-developed healthcare infrastructure, higher number of target population, wide availability of urinary self-catheter systems, and supportive reimbursement policies for usage of these catheter. However, Asia-Pacific is expected to experience the highest growth rate during the forecast period, majorly due to rise in target population along with increase in adoption of urinary self-catheter systems.
- Based on product, the intermittent catheters segment held 84.9% self-catheters market share in the global market in 2018.
- Depending on type, the female type catheter segment is expected to exhibit fastest growth, registering a CAGR of 4.4% from 2019 to 2026.
- By application, the spinal cord injuries segment held largest market share in 2018, and is expected to remain dominant throughout the forecast period.
- Region wise, Asia-Pacific is expected to experience highest growth rate, registering a CAGR of 5.6% during the forecast period.
Key Topics Covered
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. Key findings
2.2.1. Top investment pockets
2.2.2. Top impacting factors
2.3. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key forces shaping urinary self-catheter industry/market
3.3. Government regulations on global urinary self-catheter market
3.4. Market dynamics
184.108.40.206. Increase in incidence of urinary disorders
220.127.116.11. Rise in geriatric population
18.104.22.168. Favorable reimbursement policies
22.214.171.124. Rise in adoption of hydrophilic catheters
126.96.36.199. Surge in healthcare expenditure worldwide
188.8.131.52. Availability of alternatives to urinary self-catheters
184.108.40.206. Lack of awareness towards utilization of self-catheters
220.127.116.11. Emerging economies to offer lucrative opportunities
18.104.22.168. Innovations in urinary catheters and novel product launches
3.4.4. Impact analysis
CHAPTER 4: URINARY SELF-CATHETER MARKET, BY PRODUCT TYPE
4.2. Intermittent catheters
4.3. External catheters
CHAPTER 5: URINARY SELF-CATHETER MARKET, BY TYPE
5.2. Male type catheter
5.3. Female type catheter
CHAPTER 6: URINARY SELF-CATHETER MARKET, BY APPLICATION
6.2. Benign prostate hyperplasia (BPH)
6.3. Urinary incontinence
6.4. Spinal cord injuries
CHAPTER 7: URINARY SELF-CATHETER MARKET, BY REGION
7.2. North America
CHAPTER 8: COMPETITIVE LANDSCAPE
8.2. Competitive dashboard
8.3. Competitive heatmap
CHAPTER 9: COMPANY PROFILES
9.1. Asid Bonz GmbH
9.2. B Braun Melsungen AG
9.3. Becton, Dickinson and Company (C.R. Bard)
9.4. Boston Scientific Corporation
9.5. Coloplast A/S
9.7. Hollister, Inc.
9.8. Medtronic PLC
9.9. Medical Technologies of Georgia, Inc.
9.10. Teleflex Incorporated
For more information about this report visit https://www.researchandmarkets.com/r/y59qto